<?xml version="1.0"?>

<document>
	<title>Cystic fibrosis: decreased thermostability of alpha-mannosidase in
   crude extracellular fluids of patients and carriers.</title>

	<author>Hosli-P.</author>
	<author>Vogt-E.</author>

	<source>FEBS-Lett. 1979 Aug 15. 104(2). P 271-4.</source>

	<abstract>We wish to demonstrate that an abnormal thermostability has been
   found in crude extracellular fluids for alpha-mannosidase.  More
   extensive studies involving several of the &apos;leaky&apos; hydrolases are
   under way and they indicate that the observed thermolabilities can
   be exploited to develop the urgently needed simple diagnostic tools
   for cystic fibrosis.</abstract>

	<majorsubject>CYSTIC-FIBROSIS: en</majorsubject>
	<majorsubject>EXTRACELLULAR-SPACE: en</majorsubject>
	<majorsubject>MANNOSIDASES: me</majorsubject>
	<majorsubject>SKIN: en</majorsubject>

	<minorsubject>CELLS-CULTURED</minorsubject>
	<minorsubject>DRUG-STABILITY</minorsubject>
	<minorsubject>FIBROBLASTS: en</minorsubject>
	<minorsubject>HEAT</minorsubject>
	<minorsubject>HETEROZYGOTE</minorsubject>
	<minorsubject>HUMAN</minorsubject>
	<minorsubject>KINETICS</minorsubject>

	<reference>001   WOOD RE               AM REV RESPIR DIS              113   833 976</reference>
	<reference>002   DI SANTAGNESE PA      N ENGL J MED                   295   481 976</reference>
	<reference>003   GIBSON LE             PEDIATRICS                      23   545 959</reference>
	<reference>004   SCHWARZ V             ARCH DIS CHILD                  43   695 968</reference>
	<reference>005   STEPHAN U             PEDIATRICS                      55    35 975</reference>
	<reference>006   HOSLI P               BIOCHEM BIOPHYS RES COMMUN      73   209 976</reference>
	<reference>007   PAPP Z                CLIN GENET                      11   431 977</reference>
	<reference>008   BRESLOW JL            SCIENCE                        201   180 978</reference>
	<reference>009   HOSLI P               BIOCHEM BIOPHYS RES COMMUN      79   741 977</reference>
	<reference>010   HOSLI P               PROC INT CF CONG 7TH                 278 976</reference>
	<reference>011   HOSLI P               MONOGR PAEDIATR                 10    90 979</reference>
	<reference>012   NEUFELD EF            J SUPRAMOL STRUCT                6    95 977</reference>
	<reference>013   KAPLAN A              PROC NAT ACAD SCI USA           74  2026 977</reference>

	<citation>1   HIRANI S              LANCET                           2   906 979</citation>
	<citation>2   HOSLI P               FEBS LETTERS                   106  U421 979</citation>
	<citation>3   BUTTERWORTH J         CLIN CHIM ACTA                 108   347 980</citation>
	<citation>4   CAREY WF              MED J AUST                       2   314 982</citation>
	<citation>5   CRISTOL P             SEM HOP PARIS                   58   449 982</citation>
	<citation>6   CEDER O               CLIN GENET                      23   298 983</citation>
	<citation>7   CEDER O               ACTA PAEDIATR SCAND             72   291 983</citation>
	<citation>8   KOHLSCHUTTER A        FEBS LETTERS                   155   223 983</citation>
	<citation>9   CEDER O               ACTA PAEDIATR SCAND SUPPL 309 1983     1 983</citation>
	<citation>10   BOZON D               ARCH BIOCHEM BIOPHYS           249   546 986</citation>

</document>
